Kimberly-Clark Sees Operating Profit Down Low To Mid-single Digits Percent In 2022

Kimberly-Clark Corporation (KMB) said, for 2022, the company projects: operating profit to be down low to mid-single digits percent compared to adjusted operating profit in 2021. Earnings per share is projected in a range of $5.60 to $6.00. Analysts polled by Thomson Reuters expect the company to report profit per share of $6.70. Analysts' estimates typically exclude special items.

For 2022, the company targets net sales increase of 1 to 2 percent. Organic sales are expected to increase 3 to 4 percent.

For 2022, the company projects dividend increase of 1.8 percent. The quarterly dividend will increase to $1.16 per share, up from $1.14 per share in 2021. The first dividend will be payable on April 4, 2022 to stockholders of record on March 4, 2022. Share repurchases are estimated to be approximately $100 million.

Fourth-quarter adjusted profit per share was $1.30 compared to $1.69, prior year.
Analysts on average had expected the company to earn $1.25 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

Net profit was $357 million, or $1.06 per share compared to $539 million, or $1.58 per share, prior year.

The company's revenue for the quarter rose 2.7% to $4.97 billion from $4.84 billion last year. Analysts on average had estimated $4.90 billion in revenue.

Shares of Kimberly-Clark were down 5% in pre-market trade on Wednesday.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Salt Lake City, Utah-based Creminelli Fine Meats is recalling around 4,207 pounds of ready-to-eat or RTE parmesan salami sticks citing misbranding and an undeclared allergen, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. The recall involves 2.6-oz. plastic pouches containing "CREMINELLI FINE MEATS salami minis UNCURED ITALIAN SALAMI PARMESAN" with "BES The U.S. Food and Drug Administration is proposing a rule that will broaden the range of nonprescription or over-the counter drugs available to consumers. The rule titled, "Nonprescription Drug Product with an Additional Condition for Nonprescription Use," is intended to increase options for the development of safe and effective nonprescription drugs. The U.S. Food and Drug Administration announced that Australian organic infant formula and baby food producer, Bellamy's Organic, has agreed to send around 696,000 cans of general formula milk to the United States to meet the supply shortage. Under the FDA's enforcement discretion to source more infant formula to the U.S., the available Bellamy's Organic products include about 1.4 million pounds.
Follow RTT